Marc Banjak
CIK: 0002033869
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
iBio, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Mar 26, 2026IBIO
iBio, Inc.
Purchase(P)Direct12.5K shares at avg. $1.64$21K - Mar 26, 2026IBIO
iBio, Inc.
Purchase(P)Direct1.4K shares at avg. $1.76$3K - Jan 28, 2026IBIO
iBio, Inc.
Award(A)DirectStock Option (right to buy)
146K shares- - Oct 20, 2025IBIO
iBio, Inc.
Award(A)DirectStock Option (right to buy)
55K shares- - Feb 21, 2025IBIO
iBio, Inc.
Award(A)DirectStock Option (right to buy)
71K shares- - Jan 10, 2025IBIO
iBio, Inc.
Purchase(P)Direct9.2K shares at avg. $2.72$25K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 26, 2026 | IBIO iBio, Inc. | Purchase(P) | 12,500 | $1.64 | $20,531 | Direct |
| Mar 26, 2026 | IBIO iBio, Inc. | Purchase(P) | 1,434 | $1.76 | $2,524 | Direct |
| Jan 28, 2026 | IBIO iBio, Inc. | Award(A) Stock Option (right to buy) | 146,000 | - | - | Direct |
| Oct 20, 2025 | IBIO iBio, Inc. | Award(A) Stock Option (right to buy) | 55,000 | - | - | Direct |
| Feb 21, 2025 | IBIO iBio, Inc. | Award(A) Stock Option (right to buy) | 71,000 | - | - | Direct |
| Jan 10, 2025 | IBIO iBio, Inc. | Purchase(P) | 9,191 | $2.72 | $25,000 | Direct |
1-6 of 6 transactions
About Banjak Marc
Banjak Marc (SEC CIK 0002033869) files insider reports with the SEC as Chief Legal Officer of iBio, Inc. (IBIO).
Signal8 holds 5 ownership filings by Banjak Marc, all Form 4s, filed between Jan 13, 2025 and Mar 27, 2026. Those filings report 6 transactions, from Jan 10, 2025 to Mar 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Banjak Marc's filings is in SAN DIEGO, CA.
Recent filings by Banjak Marc
- Mar 26, 2026: Open-market purchases of IBIO shares (2 lines, Form 4, code P).
- Jan 28, 2026: Grant or award of IBIO derivative securities (Form 4, code A).
- Oct 20, 2025: Grant or award of IBIO derivative securities (Form 4, code A).
- Feb 21, 2025: Grant or award of IBIO derivative securities (Form 4, code A).
- Jan 10, 2025: Open-market purchase of IBIO shares (Form 4, code P).
Other insiders filing for iBio, Inc. (IBIO)
- Stoner Elizabeth, Director
- Kropotova Alexandra, Director
- Arkowitz David, Director
- Clark William D, Director
- Parada Antonio Bernardino Guimaraes, Director
- Sender Gary, Director